国际肿瘤学杂志

国际肿瘤学杂志 ›› 2013, Vol. 40 ›› Issue (1): 54-57.

• 综述 • 上一篇    下一篇

老年晚期非小细胞肺癌研究进展

李小龙, 陆婉玲, 党亚正   

  1. 710054西安，解放军第323医院肿瘤中心
  • 出版日期:2013-01-08 发布日期:2013-01-15
  • 通讯作者: 陆婉玲，E-mail：lwldst@sina.com E-mail:lwldst@sina.com
  • 基金资助:

    陕西省自然科学基金（2012JM4008）

Progress of non-small-cell lung cancer in the elderly patients

LI  Xiao-Long, LU  Wan-Ling, DANG  Ya-Zheng   

  1. Cancer Center, 323 Hospital of PLA,  Xi’an 710054, China
  • Online:2013-01-08 Published:2013-01-15
  • Contact: Corresponding author: LU Wan-ling, E-mail: lwldst@sina.com E-mail:lwldst@sina.com

PDF

1373

被引次数

4

摘要： 老年晚期非小细胞肺癌（NSCLC）的治疗目前尚无统一标准，但一般状况较好的老年患者，单纯放疗或化疗已逐渐成为治疗的主要措施。同步放化疗的综合治疗也能使部分老年患者获益，值得进一步的临床研究。靶向治疗疗效确切，不良反应小，为老年晚期NSCLC的治疗提供了新的治疗模式，但经济负担较重，一般家庭不能接受，故靶向药物及靶向药物与传统抗肿瘤治疗模式的结合尚不能广泛开展。

关键词: 癌, 非小细胞肺, 老年人

Abstract: At present, there is no unified standards of treatment in elderly advanced non-small cell lung cancer (NSCLC), but to elderly patients who scores of KPS is higher, radiotherapy or chemotherapy alone has gradually become the main treatment measures. The concurrent chemoradiotherapy can benefit to part of the elderly patients, and it is worth further clinical research. Targeted therapy has exactly effect, and the adverse effect is mild, which provides a new treatment model for elderly advanced NSCLC patients. However, the hospital costs are relatively high, which can not be accepted by ordinary family. So targeted drugs and the model of combination treatment can not be applied extensively.

Key words: Carcinoma, non-small-cell lung, Aged